arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Alkermes plc

ALKS Health Care Biotechnology: Pharmaceutical Preparations
$44.18
▲ +0.2% Today
as of Oct 22, 16:45 ET
Last 30 days -3.60% Sep 14 → Oct 22
$38.47 $40.68 $42.90 $45.11 $47.32 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$44.00
High
$44.68
Low
$43.46
Volume
$2M
Avg Vol
$2M
Mkt Cap
$7.0B
P/E (TTM)
458.00
Beta
—
52w High
$55.67
52w Low
$27.00
Div Yield
—
Shares Out
$168M

Recent Press Releases & News last 60 days · 19 items

Oct 20 · 20:00 PR Business Wire
Alkermes to Report Third Quarter Financial Results on November 3, 2026
Oct 20 · 13:00 Zacks
Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline
Oct 13 · 11:00 PR Business Wire
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
▸ Show all 19 press releases & news Free account →

ALKS earnings at a glance

Alkermes plc (ALKS) is scheduled to report earnings on Tuesday, October 27, 2026 — in 4 days. Analysts expect earnings per share of -$0.08, compared with $0.49 in the same quarter last year (-116%). The options market is pricing a move of about ±5.9% after the report, a range of roughly $41.57 to $46.79 from today's $44.18. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±5.2% on average; after the most recent report on Jul 28, 2026 it moved -4.2%. That means options currently expect about the same movement than ALKS has typically delivered. ALKS beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 47%. The share price of $44.18 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$27
$56
60% of range
Avg surprise (last 6)
+38.2%
Avg reaction (last 6)
+1.4%
67% positive
Latest IV / EM
47%
EM ±5.9% · $41 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.57$-0.08$0.40$0.89$1.38 Actual $-0.25Actual $1.38Actual $0.28Actual $0.21Actual $0.53Actual $0.55Actual $0.13Est $0.18Actual $0.52Est $0.30Actual $0.49Est $0.34Actual $0.34Est $0.31Actual $-0.40Est $-0.57Est $-0.04 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-66M$80M$227M$374M$521M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jul 28, 2026Jun/2026 — $-0.04 +100.0% -107.7% -4.2% earnings
Tue May 5, 2026Mar/2026 $-0.40 $-0.57 +29.8% -407.7% +6.1% earnings
Wed Feb 25, 20268K 2026-02-25 $0.34 $0.31 +9.7% — -7.0% earnings
Tue Oct 28, 2025Sep/2025 $0.49 $0.34 +44.1% — +4.3% earnings
Tue Jul 29, 2025Jun/2025 $0.52 $0.30 +73.3% — +3.2% earnings
Thu May 1, 2025Mar/2025 $0.13 $0.18 -27.8% — +6.3% earnings
Mon Sep 30, 2024Sep 2024 $0.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.53 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.28 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.38 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.25 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Oct 27, 2026Sep/2026OTHER -$0.08$0.49 -116.3%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$496M$393M—$394M$391M$307M—$378M
Cost of revenue$98M$62M—$52M$49M$49M—$63M
Gross profit————————
Operating income$18M$-48M—$89M$93M$14M—$105M
Net income$501,000$-66M—$83M$87M$22M—$92M
EPS (diluted)—$-0.40—$0.49$0.52$0.13—$0.55

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$512M$352M$389M$616M$521M$400M$291M$396M
Inventory$299M$337M$197M$191M$192M$183M$183M$191M
Total current assets$1.52B$1.36B$1.93B$1.74B$1.64B$1.48B$1.42B$1.56B
Total assets$4.39B$4.26B$2.49B$2.33B$2.25B$2.08B$2.06B$2.16B
Long-term debt$1.48B$1.48B$0————$286M
Total liabilities$2.58B$2.51B$668M$596M$628M$570M$591M$863M
Total equity$1.81B$1.75B$1.82B$1.73B$1.62B$1.51B$1.46B$1.29B

Implied volatility — last 90 days

27%67%108%148%189% Jun 07 — IV 56% · EM ±7.7%Jun 08 — IV 58% · EM ±7.7%Jun 09 — IV 52% · EM ±6.5%Jun 10 — IV 50% · EM ±5.9%Jun 11 — IV 57% · EM ±6.3%Jun 12 — IV 54% · EM ±5.5%Jun 15 — IV 65% · EM ±4.7%Jun 16 — IV 52% · EM ±3.1%Jun 17 — IV 98% · EM ±4.1%Jun 19 — IV 49% · EM ±10.9%Jun 22 — IV 44% · EM ±9.3%Jun 23 — IV 45% · EM ±9.2%Jun 24 — IV 44% · EM ±8.9%Jun 25 — IV 54% · EM ±10.6%Jun 26 — IV 51% · EM ±9.8%Jun 29 — IV 56% · EM ±9.9%Jun 30 — IV 53% · EM ±9.1%Jul 01 — IV 49% · EM ±8.3%Jul 02 — IV 46% · EM ±7.4%Jul 03 — IV 47% · EM ±7.4%Jul 06 — IV 51% · EM ±7.1%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 47% · EM ±5.9%Jul 09 — IV 48% · EM ±5.7%Jul 10 — IV 70% · EM ±7.7%Jul 13 — IV 68% · EM ±5.6%Jul 14 — IV 109% · EM ±7.8%Jul 15 — IV 160% · EM ±9.4%Jul 16 — IV 189% · EM ±7.9%Jul 20 — IV 53% · EM ±12.6%Jul 21 — IV 58% · EM ±13.4%Jul 22 — IV 53% · EM ±12.2%Jul 23 — IV 54% · EM ±12.1%Jul 24 — IV 54% · EM ±11.9%Jul 27 — IV 62% · EM ±12.9%Jul 28 — IV 50% · EM ±10.1%Jul 29 — IV 53% · EM ±10.6%Jul 30 — IV 54% · EM ±10.5%Jul 31 — IV 44% · EM ±8.5%Aug 03 — IV 40% · EM ±7.0%Aug 04 — IV 45% · EM ±7.8%Aug 05 — IV 63% · EM ±10.6%Aug 06 — IV 48% · EM ±7.8%Aug 07 — IV 38% · EM ±5.9%Aug 10 — IV 47% · EM ±6.5%Aug 11 — IV 49% · EM ±6.5%Aug 12 — IV 59% · EM ±7.4%Aug 13 — IV 48% · EM ±5.6%Aug 14 — IV 65% · EM ±7.1%Aug 17 — IV 34% · EM ±2.8%Aug 18 — IV 65% · EM ±4.7%Aug 20 — IV 59% · EM ±2.4%Aug 24 — IV 40% · EM ±8.3%Aug 25 — IV 43% · EM ±8.8%Aug 26 — IV 37% · EM ±7.4%Aug 27 — IV 27% · EM ±5.4%Aug 28 — IV 51% · EM ±9.8%Aug 31 — IV 52% · EM ±9.2%Sep 01 — IV 43% · EM ±7.4%Sep 02 — IV 57% · EM ±9.5%Sep 03 — IV 46% · EM ±7.5%Sep 04 — IV 56% · EM ±8.8%Sep 07 — IV 63% · EM ±8.8%Sep 08 — IV 55% · EM ±7.2%Sep 09 — IV 62% · EM ±7.7%Sep 10 — IV 67% · EM ±7.9%Sep 15 — IV 65% · EM ±4.7%Sep 21 — IV 51% · EM ±10.8%Sep 22 — IV 42% · EM ±8.6%Sep 23 — IV 45% · EM ±9.0%Sep 24 — IV 45% · EM ±8.8%Sep 25 — IV 47% · EM ±9.1%Sep 28 — IV 37% · EM ±6.5%Sep 29 — IV 49% · EM ±8.5%Sep 30 — IV 50% · EM ±8.4%Oct 02 — IV 42% · EM ±6.5%Oct 06 — IV 50% · EM ±6.5%Oct 07 — IV 47% · EM ±5.9%

Sector peers

IONS
Ionis Pharmaceuticals, Inc.
$7.3B $43.91-3.3%
BLTE
Belite Bio, Inc
$6.6B $150.27-2.7%
KNSA
Kiniksa Pharmaceuticals International, plc
$6.1B $80.79-2.9%
LGND
Ligand Pharmaceuticals Incorporated
$5.8B $307.82+0.5%
CYTK
Cytokinetics, Incorporated
$8.5B $62.33-2.5%
PTCT
PTC Therapeutics, Inc.
$5.3B $63.04+0.2%

ALKS earnings FAQ

When is ALKS's next earnings date?

Alkermes plc is expected to report on October 27, 2026.

What is ALKS's expected move for earnings?

Options currently price a move of about ±5.9%, or $2.61 per share either way from $44.18.

How does ALKS stock usually react to earnings?

Across the last 6 reports the average next-day move was ±5.2%, up 4 times and down 2 times.

What EPS are analysts expecting from Alkermes plc?

The consensus estimate is -$0.08 per share, versus $0.49 a year ago.

What is ALKS's implied volatility?

ALKS's at-the-money implied volatility is about 47% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in